<!DOCTYPE html>
<html lang="en">
	<head>
		<title>Offering Memorandum</title>
		<meta charset="utf-8">
		<link rel="stylesheet" type="text/css" href="../acmeSolutions.css">
		<!--[if IE 9]>
		<script src="http://html5shim.googlecode.com/svn/trunk/html5.js">
		</script>
		<![endif]-->
		<meta name="viewport" content="width=device-width, initial-scale=1.0">
		<link rel="icon" href="../Images/favicon.ico">

	</head>
	<body>
		<nav>
			<a href="../index.html"><img src="../Images/logo.png" alt="logo"></a>
			<form>
				<input type="text" name="siteSearch" id="siteSearch" placeholder="Search...">
			</form>
			<ul>
				<li><a href="../index.html">Home</a></li>
				<li><a href="../about.html">About Us</a></li>
				<li class="dropdown"><a href="javascript:void(0);">Research</a>
					<ul class="dropLinks">
						<li><a href="../Research/publications.html">&#8250; Publications</a></li>
						<li><a href="../Research/Rhinotillexomania.html">&#8250; Rhinotillexomania</a></li>
					</ul>
				</li>
				<li class="dropdown"><a id="active" href="javascript:void(0);">Investment</a>
					<ul class="dropLinks">
						<li><a href="proposal.html">&#8250; Offering Memorandum</a></li>
						<li><a href="apply.html">&#8250; Investment Application</a></li>
					</ul>
				</li>
				<li><a href="../contact.html">Contact</a></li>
			</ul>
			<div id="translate">
				<a href="https://en.wikipedia.org/wiki/Chinese_language" lang="zh-Hans">中文</a>
				<a href="https://en.wikipedia.org/wiki/Spanish_language" lang="es">Español</a>
				<a href="https://en.wikipedia.org/wiki/French_language" lang="fr">Français</a>
			</div>
		</nav>
		<header>
			<h1 id="other">Offering Memorandum</h1>
		</header>
			<main>
				<h2>Looking Forward</h2>
				<div class="content">
					Help us move our research forward into the next phases of clinical trials. 
					With your contribution, we can make rhinotillexomania an ailment of the past. The offer as it stands
					is a 100% exemption from both Provincial and Federal Taxes in perpetuity <span style="color:#36a334">*</span>, as well as a lifetime supply of tissue paper
					form our corporate sponsors.<br>
					<ul>
						<li><span>Donec dapibus, felis sed pulvinar pharetra, tortor risus lacinia elit, in accumsan dolor nulla vel eros.</span></li>
						<li><span>Donec vestibulum ante id ante lobortis, sed ultricies diam tincidunt. Cras euismod elementum.</span></li>
						<li><span>Maecenas euismod nunc vehicula, aliquam risus et, faucibus massa.</span></li>
						<li><span>Nulla scelerisque ac ex id rhoncus. Aliquam a leo et sapien pharetra malesuada. Integer elementum euismod
						velit rutrum faucibus. Morbi dapibus arcu et tellus feugiat, nec tempor.</span></li>
						<li><span>Vivamus eleifend elementum eros eget egestas. Phasellus sit amet vulputate lorem. Donec euismod enim vitae interdum tempor.</span></li>
						<li><span>Nunc tincidunt libero ut pharetra ultricies. Curabitur porta dapibus orci, a euismod ante. Pellentesque dictum posuere odio, sed pharetra lectus tempor nec.</span></li>
						<li><span>In quis velit felis. Aliquam sit amet rutrum augue, auctor dapibus ligula.</span></li>
						<li><span>Aenean pulvinar arcu id mauris auctor, eget vehicula mi placerat. Suspendisse non urna ac risus tincidunt elementum.</span></li>
					</ul>
					<div id="request"><a href="apply.html">Obtain Full Offering Memorandum</a></div>
					<div id="condition">* Terms and conditions may apply. See complete Offering Memorandum for details. Acme Solutions Inc. is not liable, responsible, acccountable, or culpable
					for any fianancial difficulties that may result as a couse of investing in our company. Acme Solutions Inc. reserves the right to keep any and all investment 
					amounts regardless of the success of the clinical trials.</div>
				</div>
			</main>
			<hr>
			<footer>
				<div id="blurb">
					<strong>The Company:</strong><br>
					Acme Solutions is a Canadian owned and operated biotechnology company 
					specializing in the development of pharmaceutical drugs
					for the treatment of rhinotillexomania.
					<br>
				</div>
				<div id="copy">Copyright &copy; 2017 Acme Solutions Inc.- Designed by <span id="me">A.Z</span></div>
			</footer>
	</body>
</html>